Radhakrishnan Karthik

Radhakrishnan Karthik is listed in filings as Chief Financial Officer at Monopar Therapeutics Inc.. This profile follows SEC Form 4 activity through Oct 30, 2024, including purchase activity. Recent filings connect the profile to Monopar Therapeutics Inc. (MNPR). The current snapshot covers public activity from Jul 3, 2024 to Oct 30, 2024. Reported amounts are shown as $92.7K to $25.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.